London, United Kingdom: TEBillion, one of the leading business automation solutions provider, is gaining a large increase of interest from the pharmaceutical industry.
The pharmaceutical industry is no stranger to the challenging impact of COVID19. With the rise in the demand and limiting the number of workforce with work from home arrangements, pharmaceutical distribution companies are starting to understand the COVID19 impact. These companies are approaching TEBillion to integrate business automation solutions to ensure ease and efficiency in their processes.
Amit Raina, SVP South East Asia announced this week that TEB is getting more inquiries from the pharmaceutical distribution companies in the past few weeks and a couple of agreements are anticipated.
The rise in the demand with a limited number of the workforce means that the pharmaceutical distribution companies need to be more certain as to how their sales processes are going that will allow them to have a more comprehensive view of how the pandemic has affected the company. This will ultimately help them make important business decisions.
TEBillion will provide cost-effective automation solutions with after-sales support allowing the companies to be more flexible and adaptable during this pandemic.
For more information about TEBillion's products and services, contact:
Email: [email protected]
About TEBillion: TEBillion is a business automation software solutions company headquartered in the UK. Born in 2018, TEBillion aims to make high growth businesses successful with over a hundred handpicked partners serving customers, worldwide.